Sphingolipids are both structural and bioactive compounds. In particular, ceramide and sphingosine 1-phosphate regulate cell fate, inflammation and excitability. 1-α,25-dihydroxyvitamin D3 (1,25(OH)2D3) is known to play an important physiological role in growth and differentiation in a variety of cell types, including neural cells, through genomic actions mediated by its specific receptor, and non-genomic effects that result in the activation of specific signalling pathways. 1,25(OH)2D3 and sphingolipids, in particular sphingosine 1-phosphate, share many common effectors, including calcium regulation, growth factors and inflammatory cytokines, but it is still not known whether they can act synergistically. Alterations in the signalling and concentrations of sphingolipids and 1,25(OH)2D3 have been found in neurodegenerative diseases and fingolimod, a structural analogue of sphingosine, has been approved for the treatment of multiple sclerosis. This review, after a brief description of the role of sphingolipids and 1,25(OH)2D3, will focus on the potential crosstalk between sphingolipids and 1,25(OH)2D3 in neural cells

Crosstalk between sphingolipids and vitamin D3: potential role in the nervous system

GARCIA GIL, MARIA de las MERCEDES;
2017-01-01

Abstract

Sphingolipids are both structural and bioactive compounds. In particular, ceramide and sphingosine 1-phosphate regulate cell fate, inflammation and excitability. 1-α,25-dihydroxyvitamin D3 (1,25(OH)2D3) is known to play an important physiological role in growth and differentiation in a variety of cell types, including neural cells, through genomic actions mediated by its specific receptor, and non-genomic effects that result in the activation of specific signalling pathways. 1,25(OH)2D3 and sphingolipids, in particular sphingosine 1-phosphate, share many common effectors, including calcium regulation, growth factors and inflammatory cytokines, but it is still not known whether they can act synergistically. Alterations in the signalling and concentrations of sphingolipids and 1,25(OH)2D3 have been found in neurodegenerative diseases and fingolimod, a structural analogue of sphingosine, has been approved for the treatment of multiple sclerosis. This review, after a brief description of the role of sphingolipids and 1,25(OH)2D3, will focus on the potential crosstalk between sphingolipids and 1,25(OH)2D3 in neural cells
2017
GARCIA GIL, MARIA de las MERCEDES; Pierucci, F; Vestri, A; Meacci, E.
File in questo prodotto:
File Dimensione Formato  
Garcia-Gil_et_al-2017-British_Journal_of_Pharmacology.pdf

solo utenti autorizzati

Tipologia: Versione finale editoriale
Licenza: NON PUBBLICO - Accesso privato/ristretto
Dimensione 1.56 MB
Formato Adobe PDF
1.56 MB Adobe PDF   Visualizza/Apri   Richiedi una copia
Fig 4 finali review BJP 12 dic.pdf

accesso aperto

Descrizione: figura 4
Tipologia: Documento in Post-print
Licenza: Creative commons
Dimensione 24.47 kB
Formato Adobe PDF
24.47 kB Adobe PDF Visualizza/Apri
Fig 3 new.pdf

accesso aperto

Descrizione: figura 3
Tipologia: Documento in Post-print
Licenza: Creative commons
Dimensione 513.1 kB
Formato Adobe PDF
513.1 kB Adobe PDF Visualizza/Apri
Fig 2.pdf

accesso aperto

Descrizione: figura 2
Tipologia: Documento in Post-print
Licenza: Creative commons
Dimensione 429.91 kB
Formato Adobe PDF
429.91 kB Adobe PDF Visualizza/Apri
Fig 1B.pdf

accesso aperto

Descrizione: figura 1B
Tipologia: Documento in Post-print
Licenza: Creative commons
Dimensione 430.41 kB
Formato Adobe PDF
430.41 kB Adobe PDF Visualizza/Apri
figure 1A SL metabolism.pdf

accesso aperto

Descrizione: figura 1A
Tipologia: Documento in Post-print
Licenza: Creative commons
Dimensione 161.71 kB
Formato Adobe PDF
161.71 kB Adobe PDF Visualizza/Apri
Garcia-Gil et al. BJP 190117 +tables.pdf

accesso aperto

Descrizione: articolo principale
Tipologia: Documento in Post-print
Licenza: Creative commons
Dimensione 473.97 kB
Formato Adobe PDF
473.97 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11568/857116
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 10
  • ???jsp.display-item.citation.isi??? 10
social impact